Several anti IL-6 therapies are currently available or under investigation. These include:
Tocilizumab: A monoclonal antibody against the IL-6 receptor, used in the treatment of rheumatoid arthritis and being investigated for gynecological applications. Sarilumab: Another monoclonal antibody targeting the IL-6 receptor, with potential applications in inflammatory gynecological conditions. Siltuximab: A monoclonal antibody targeting IL-6 itself, used for treating Castleman's disease and under research for other inflammatory diseases.
